Literature DB >> 7473178

Closed- and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5.

R Bouchard1, D Fedida.   

Abstract

The effect of 4-aminopyridine (4-AP) on membrane and gating currents of Kv1.5 channels was studied in a human cell line. The rank order of block was cell-attached > whole cell >> outside-out macropatches, which suggested that 4-AP blocked channels from the cytosolic face. Stimulation after exposure to 4-AP during rest resulted in a "supernormal" current immediately after the onset of depolarization, followed by open channel block during maintained depolarization. 4-AP remained trapped in closed channels, and unblock after drug washout required depolarization. At higher concentrations, 4-AP induced channel block by binding to closing or nonconducting channels. This effect could be reduced by hyperpolarization and higher pulsing rates. Block of Kv1.5 channels under steady-state conditions was correlated with a dose-dependent reduction in gating charge movement. The normalized voltage dependence of gating was shifted to more negative potentials by 4-AP. A model incorporating both open and closed channel binding of 4-AP reproduced data, including the "supernormal" current, by shifting the Po - V curve slightly to the left. The results show that 4-AP can both enhance and block Kv1.5 current and suggest that 4-AP can bind with different affinities to more than one site on Kv1.5 channels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473178

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

1.  Regulation of transient Na+ conductance by intra- and extracellular K+ in the human delayed rectifier K+ channel Kv1.5.

Authors:  Z Wang; X Zhang; D Fedida
Journal:  J Physiol       Date:  2000-03-15       Impact factor: 5.182

2.  Gating charge and ionic currents associated with quinidine block of human Kv1.5 delayed rectifier channels.

Authors:  D Fedida
Journal:  J Physiol       Date:  1997-03-15       Impact factor: 5.182

3.  Gating current studies reveal both intra- and extracellular cation modulation of K+ channel deactivation.

Authors:  Z Wang; X Zhang; D Fedida
Journal:  J Physiol       Date:  1999-03-01       Impact factor: 5.182

4.  A rapidly activating sustained K+ current modulates repolarization and excitation-contraction coupling in adult mouse ventricle.

Authors:  C Fiset; R B Clark; T S Larsen; W R Giles
Journal:  J Physiol       Date:  1997-11-01       Impact factor: 5.182

5.  Modulation of Kv1.5 potassium channel gating by extracellular zinc.

Authors:  S Zhang; S J Kehl; D Fedida
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

6.  Mechanisms of Kv2.1 channel inhibition by celecoxib--modification of gating and channel block.

Authors:  R V Frolov; V E Bondarenko; S Singh
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

7.  Slow gating charge immobilization in the human potassium channel Kv1.5 and its prevention by 4-aminopyridine.

Authors:  D Fedida; R Bouchard; F S Chen
Journal:  J Physiol       Date:  1996-07-15       Impact factor: 5.182

8.  Chlorthalidone inhibits the KvLQT1 potassium current in guinea-pig ventricular myocytes and oocytes from Xenopus laevis.

Authors:  C Mancilla-Simbro; A López; E Martinez-Morales; E Soto-Perez-de-Celis; L Millan-PerezPeña; R Tsushima; E M Salinas-Stefanon
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

9.  Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes.

Authors:  S L Archer; E Souil; A T Dinh-Xuan; B Schremmer; J C Mercier; A El Yaagoubi; L Nguyen-Huu; H L Reeve; V Hampl
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

10.  The plateau outward current in canine ventricle, sensitive to 4-aminopyridine, is a constitutive contributor to ventricular repolarization.

Authors:  A Sridhar; D N Q da Cunha; V A Lacombe; Q Zhou; J J Fox; R L Hamlin; C A Carnes
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.